JPS5312839A - Improvement of organic compound - Google Patents

Improvement of organic compound

Info

Publication number
JPS5312839A
JPS5312839A JP8517677A JP8517677A JPS5312839A JP S5312839 A JPS5312839 A JP S5312839A JP 8517677 A JP8517677 A JP 8517677A JP 8517677 A JP8517677 A JP 8517677A JP S5312839 A JPS5312839 A JP S5312839A
Authority
JP
Japan
Prior art keywords
improvement
organic compound
organic
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP8517677A
Other languages
English (en)
Inventor
Puresu Yanosu
Zandorin Edomondo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH920776A external-priority patent/CH622495A5/de
Priority claimed from CH920976A external-priority patent/CH622244A5/de
Priority claimed from CH921076A external-priority patent/CH622496A5/de
Priority claimed from CH1206576A external-priority patent/CH623565A5/de
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of JPS5312839A publication Critical patent/JPS5312839A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/70—Enkephalins
    • C07K14/702—Enkephalins with at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Psychiatry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Indole Compounds (AREA)
JP8517677A 1976-07-19 1977-07-18 Improvement of organic compound Pending JPS5312839A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH920776A CH622495A5 (en) 1976-07-19 1976-07-19 Process for the preparation of novel polypeptide derivatives
CH920976A CH622244A5 (en) 1976-07-19 1976-07-19 Process for the preparation of novel polypeptide derivatives
CH921076A CH622496A5 (en) 1976-07-19 1976-07-19 Process for the preparation of novel polypeptide derivatives
CH1206576A CH623565A5 (en) 1976-09-23 1976-09-23 Process for the preparation of polypeptide derivatives

Publications (1)

Publication Number Publication Date
JPS5312839A true JPS5312839A (en) 1978-02-04

Family

ID=27429201

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8517677A Pending JPS5312839A (en) 1976-07-19 1977-07-18 Improvement of organic compound

Country Status (6)

Country Link
JP (1) JPS5312839A (ja)
BE (1) BE856899A (ja)
DE (1) DE2730851A1 (ja)
FR (1) FR2359120A1 (ja)
GB (1) GB1587427A (ja)
NL (1) NL7707894A (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2752341A1 (de) * 1976-11-23 1978-05-24 Wellcome Found Biologisch wirksame amide, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische formulierungen
DE2819277A1 (de) * 1977-05-16 1978-11-23 Sandoz Ag Neue polypeptidderivate, ihre herstellung und verwendung
HU182051B (en) * 1978-05-02 1983-12-28 Takeda Chemical Industries Ltd Process for preparing tetrapeptide-hydrazyde derivatives
US4277394A (en) * 1979-04-23 1981-07-07 Takeda Chemical Industries, Ltd Tetrapeptidehydrazide derivatives
DE2941790A1 (de) * 1979-10-16 1981-04-30 Hoechst Ag, 6000 Frankfurt Verwendung motilitaetssteigernder peptide
SU1460965A1 (ru) * 1987-06-19 1991-10-15 Всесоюзный кардиологический научный центр АМН СССР Гексапептид, обладающий противо звенным действием
NZ233071A (en) * 1989-03-30 1993-02-25 Sumitomo Pharma Neurotrophic peptides, extraction from mammalian hippocampal tissue and pharmaceutical compositions thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ183712A (en) * 1976-04-08 1979-10-25 Ici Ltd Polypeptide analogues of enkephalins, and pharmaceutical compositions

Also Published As

Publication number Publication date
FR2359120B1 (ja) 1980-01-18
FR2359120A1 (fr) 1978-02-17
GB1587427A (en) 1981-04-01
DE2730851A1 (de) 1978-01-26
NL7707894A (nl) 1978-01-23
BE856899A (fr) 1978-01-18

Similar Documents

Publication Publication Date Title
JPS5366440A (en) Improvement of organic compound
JPS53139789A (en) Improvement of organic compound
JPS57176918A (en) Conversion of organic compounds
ZA7757B (en) Organic compounds
JPS5356684A (en) Improvement concerning organic compound
JPS5251014A (en) Improvement of organic compound
JPS5295631A (en) Improvement of organic compound
JPS5422364A (en) Improvement of organic compound
JPS5293766A (en) Improvement of organic compound
JPS51115467A (en) Improvement of organic compound
CY1261A (en) Organic compounds
JPS5223073A (en) Improvement of organic compound
JPS5312839A (en) Improvement of organic compound
ZA774756B (en) Organic compounds
AU2405177A (en) Organic compounds
JPS5268173A (en) Improvement of organic compound
JPS52261A (en) Improvement of organic compound
JPS5344598A (en) Improvement concerning about organic compound
JPS5686167A (en) Improvement of organic compound
JPS5412360A (en) Improvement of organic compound
JPS5273881A (en) Improvement of organic compound
JPS5377031A (en) Organic compound
JPS523053A (en) Improvement of organic compound
JPS52139051A (en) Improvement of organic compound
JPS54126736A (en) Improvement of organic compound